Editorial
Infection following surgical procedures, including foot and ankle surgery, poses a real challenge, as there is little evidence to guide clinicians in the prevention, diagnosis, or treatment of this dreaded complication. In July 2018, several hundred delegates from 98 countries gathered in Philadelphia, PA, as part of the International Consensus Meeting (ICM) on orthopedic infections to discuss these issues. Surgeons, physicians, and scientists worked together over a 2-year period to help more clearly delineate the best way to prevent, diagnose, and treat orthopedic infections. In addition to discussing general infection concerns, delegates worked in subspecialty workgroups to identify issues pertaining to those respective fields, including foot and ankle surgery. This supplement represents the collaborative efforts of nearly 20 orthopedic foot and ankle surgeons and infectious disease specialists from across the globe that culminated in generating this document. Each question and issue was thoroughly researched and the consensus developed following the strict Delphi criteria. The recommendations are based on detailed analysis of the current available literature and the personal experience of internationally renowned physicians experienced in foot and ankle surgery.
In light of increasing attempts at cost containment across healthcare systems, it is critical to understand the financial implications associated with infections following foot and ankle surgery. Based on the current peerreviewed literature and analysis of national data from the Health Care & Utilization Project (HCUPNet), each infection following total ankle arthroplasty incurs an additional cost of $19650, with a reported revision success rate of 80% to 95%. This is ever more critical as the number of total ankle arthroplasties being performed is increasing rapidly across the globe, and the trend is expected to continue into the future. The sheer rise in the number of total ankle arthroplasties and the projected incidence of infection between 0.7% and 3.5% by year 2030 will lead to an immense burden on the health care system. 1 Taking this into consideration, the primary goal of the consensus information provided here is to optimize our ability to care for our patients and provide the best possible treatment modalities.
Accepting the inevitable risk of surgical site infection, we need to ask ourselves what can we do to prevent or reduce the incidence of infection in our patients? Many preventive measures were discussed during the consensus, which included matters related to skin preparation, perioperative antibiotic administration, optimization of host prior to surgery, and so on. In the absence of evidence, the research workgroup was able to make certain recommendations. The document generated contains pertinent information related to orthopedic infections that is likely to serve its intended objective of improving patient care.
The questions contained in this supplement and their respective answers represent a guide to help manage patients with infectious complications. We invite you to read the supplement carefully and review the consensus statements that were concluded, together with the supporting references, levels of evidence, and degrees of consensus reached. We hope this information will be useful in your practices, help limit the risk of surgical infections, and guide your management when infections do occur.
